2022·6th Future Healthcare 100 Summit | Gathering China's Leading Venture Capital Forces with 20+ Top Investment Leaders Confirmed
/
2021 was a year of transformation in the capital markets. The Chinese private equity market has become increasingly mature, presenting a new market landscape. Meanwhile, the healthcare industry, hailed as the global “fifth wave of wealth” following the information technology sector, has consistently attracted significant attention.
Two major forces drive China’s business landscape: entrepreneurship and investment. Entrepreneurship is inextricably linked to the times and policy environment, while investors not only help founders navigate challenges but also gain firsthand experience of the transformation and innovation reshaping Chinese industries. Seasoned investors, by anticipating future industrial trajectories and positioning companies for competitive advantage in the next era, are undoubtedly the leading force behind China’s venture capital and private equity wave. So, how has China’s healthcare capital market evolved from a global perspective? Under the “dual-pronged” regulatory and development policies for venture capital, how should VC/PE firms seize opportunities and meet challenges?
June 14–16, 2022, co-hosted by VB100 and VCBeat2022 · The 6th Future Healthcare 100 Conferenceto be held at the Shishan International Conference Center in Suzhou, Jiangsu. This conference focuses on"Chinese Stories"Topic: Bringing together top-tier venture capital firms such as Legend Capital, Sequoia China, GTJA Investment, and Hillhouse HCare to deeply invest in the industry chain; focusing on the innovation strategies of Chinese innovative enterprises and their overseas market expansion, while linking high-quality overseas projects; grounded in innovation, integrating primary and secondary markets; balancing popularity with depth, and harnessing ecosystem momentum.Parallel Summits, Project Roadshows, Keynote Speeches, Venture Capital Roundtablesand other formats, to build an exchange and matchmaking platform for the entire medical industry chain. As of now, there have already been20+Top Investment Guests Confirmed to Attend, Gathering Core Industry Forces to Jointly Drive Innovation and Transformation in the Healthcare Sector.
Cao Wei
Partner at BlueRun Ventures
Fang Wenhan
Vice President, Investments, Danlu Capital
Hong Tan
Managing Director, Legend Capital
Hu Xubo
Managing Partner at Qiming Venture Partners
He Sidu
Managing Director, Danshi Capital
Jiang Xiaodong
Managing Partner, Changling Capital
Jing Xutian
Managing Director, 5Y Capital
Lu Gang
Partner, Legend Star
Liu Yu
Managing Partner, BGI Win-Win
Liang Yucheng
Head of Digital Therapeutics, Danlu Capital
Qiu Zejun
Co-Founder and Chairman of the Supervisory Board, Baize Medical Group
Ren Bobing
Executive Director of Sinovation Ventures
General Manager, Frontier Technology Fund
Tian Min
Partner at Yuanjing Capital
Teng Yuhang
Executive Partner, GTJA Investment Group
Wang Ying
General Manager of Chang Development
Chairman of Changfa Zhan Shares
Xu Qian
Partner at Danlu Capital
Yang Yunxia
Partner, Sequoia China
Yu Fang
Partner, Northern Light Venture Capital
Yu Zhiyun
Partner at Matrix Partners China
Zheng Yufen
Founder and Chairman of Yuyin Medical Fund
(Listed alphabetically by surname, in no particular order; more guests to be confirmed)
Top Guest Insights on Medical Trends: What New Discoveries Have Venture Capital Firms with a Chinese Heart and a Global Perspective Made?
According to statistics from the Asset Management Association of China (AMAC), as of the end of January 2022, China had more than 31,000 private equity investment funds and over 15,000 venture capital funds, reaching a new historical high. The year 2021 witnessed a surge in fund-of-funds (FOF) establishment, with local governments across the country racing to set up their own FOFs, a trend that has continued into 2022. As a parallel summit to the Top 100 Future Healthcare Conference, the LP-GP Summit, themed ““Exploring Value Creation and Value Investment in the Global Healthcare Industry’s Capital Market”With this as our core mission, we extensively connect with global healthcare investment fund partners, adopting an interactive format that includes keynote speeches, roundtable discussions, featured roadshows, and open networking to review new insights in global healthcare investment and explore future trends.
(Special Note: The LP-GP Summit is a closed-door event and requires separate ticket purchase.)
In-Depth Engagement with Ecosystem Partners: Which Innovative Achievements and High-Potential Projects Do Venture Capital Firms Aim to Accelerate?
According to statistics from VCBeat’s Orange Fruit Bureau, a total of 59 early-stage investment and financing transactions occurred in China’s healthcare sector in 2021, with the total financing amount reaching RMB 2.5 billion. The healthcare industry has become one of the most high-growth sectors today. Meanwhile, an increasing number of early-stage technology venture capital firms are beginning to “dive deep” into universities and laboratories in search of suitable projects. Conference AgendaForum on the Translation of Scientific Research Achievements,Global Healthcare Innovation Project Pitch Event、Future Healthcare Innovation Project RoadshowThree Signature Events: Forging Strong Links Between Venture Capital and Startups, Empowering Healthcare Enterprises to Engage with Top-Tier VC Firms, Integrating Key Growth Drivers Such as Industry Investment Capital, Government Policies, and Strategic Development Plans, Promoting Technology Transfer and Commercialization of Outstanding Projects in the Post-Pandemic Era, and Supporting the Sustainable Development of Enterprises Across All Sizes.
(Forum on the Translation of Scientific Research AchievementsInvestors, Roadshow ProjectsRecruitment:http://a.nxw.so/1qGqIr）
(Agenda for the Forum on the Translation of Scientific Research Achievements)
Clashing Perspectives on Hot Sectors: How Can Venture Capital Support the Emergence of World-Class Innovative Enterprises?
In recent years, an increasing number of indigenous innovations have emerged in China. Alongside the country’s economic transformation and upgrading, how to seize development opportunities and lead global innovation has become a key issue for capital markets. This conference also features25+A series of thematic forums covering hot topics in healthcare, including brain science, early cancer screening, ophthalmology, and small-molecule nucleic acid drugs. Through roundtable discussions, we connect with ecosystem partners to provide in-depth market analysis and trend forecasts, analyze investment opportunities across the industrial chain, and facilitate technological upgrades within the industry.
In the inaugural year of China’s 14th Five-Year Plan, Chinese venture capital and private equity bear the critical responsibility of supporting innovation and entrepreneurship, fostering technological advancement, and driving high-quality economic development. The Future Healthcare Top 100 Conference, centered on investment relationships with enterprises at their core, serves as a premier forum for the integration of industry and capital. It aims to facilitate effective interaction and collaboration across the industrial chain, accelerating the rapid growth of the most promising sectors and companies.
/
Conference Dates: June 14-16, 2022
Venue: Shishan International Conference Center, Suzhou, China
Limited-Time Offer: Conference All-Access Pass
Purchase Channels:Search for the “VB100” mini program on WeChat to make a purchase.
Two types of general admission passes are available for public purchase at this conference:
899 Yuan [VB100 All-Access Pass, Meals Not Included],1299 Yuan [VB100 All-Access Pass with Meals],Limited-Time Offer · Conference All-Access PassSave ¥630 off the original price, now as low as ¥269Onset:
Your trust will grant you the following benefits:
1. All-Access Pass for Forums, Exhibitions, and Interactive Activities (Separate registration required for certain segments such as LPGP)
2. On-site Resource Coordination Group
3. Authorized materials for speakers, including PPTs, conference proceedings, and public reports
4. Lunch vouchers during the conference (included only with meal tickets)
Special Note:
1. Duration of This Limited-Time OfferUpdates on key milestones from today until the next meeting;
2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is unveiled,For every 100-yuan increase, until the original price is restored;
3、After this limited-time offer ends,Ticket prices will rise to 369 yuan.Start
Scan the QR code to register for the 2022·6th Future Healthcare Top 100 Conference
Inquiry for the 2022 Future Healthcare Top 100 Conference
